The Advanced Deterministic Scorecard reveals a mixed fundamental picture: the Piotroski F-Score of 4/9 indicates stable but not robust financial health, while the absence of an Altman Z-Score prevents a clear distress risk assessment. Despite strong profitability metrics like ROE of 22.10% and solid earnings growth of 11.4%, the stock trades at a premium valuation (P/E 27.17 vs. sector avg 50.40) with weakening technical momentum (Technical Trend: 10/100). Insider selling worth $11.22M over the last six months raises caution, even as analysts maintain a strong_buy recommendation. The stock is priced above both the Graham defensive value ($107.64) and intrinsic estimate ($248.47), suggesting limited margin of safety.